Product Information
BUPROPION HCL SR 150 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0824 per EA under NDC 31722006760. Its NADAC has been published 131 times since Feb 21, 2024.
FDA first approved this application on May 31, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722006760
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216800FDA Approved
5/31/2023
TE Code
AB1
On Market Since
5/31/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 131 times since Feb 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0824 per EA |
|---|---|
| All-time high | $0.0904 (Apr 10, 2024) |
| All-time low | $0.0709 (May 22, 2024) |
| 52-week high | $0.0852 |
| 52-week low | $0.0805 |
| Median price | $0.0829 |
| Average price | $0.0821 |
| Largest weekly change | +20.0% (Jun 19, 2024) |
| Weeks tracked | 131 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0824 per EA (NDC 31722006760), effective Aug 19, 2026.
How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has held within roughly two percent of its current level. It has been tracked across 131 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?
Since Feb 21, 2024, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.0709 (May 22, 2024) to a high of $0.0904 (Apr 10, 2024), with a median of $0.0829 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0786 per EA — about 5% below BUPROPION HCL SR 150 MG TABLET.
Who manufactures BUPROPION HCL SR 150 MG TABLET?
BUPROPION HCL SR 150 MG TABLET (NDC 31722006760) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.